secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001070081-23-000033
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PTC Therapeutics annual meeting votes: all director nominees elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- Elected Class I directors: William F. Bell, Jr., Matthew B. Klein, Stephanie S. Okey, Jerome B. Zeldis; each received >58M votes for.
- Ratified Ernst & Young as independent auditor for FY2023: 69.4M for, 0.4M against, 13.6K abstain.
- Advisory say-on-pay proposal approved: 65.3M for, 1.5M against, 21.7K abstain, 3.0M broker non-votes.
- 74.0M shares outstanding as of record date April 13, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000107008123000033/0001070081-23-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000107008123000033/tmb-20230606x8k.htm
  HTML page:      https://secwatch.observer/filing/0001070081-23-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer